Royce & Associates LP

SEC CIK: 0000906304
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

OVID holding history

Ovid Therapeutics Inc. in every 13F filed by Royce & Associates LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

OVID overview All 13F holders of OVID Full Q2 2026 holdings

Shares (Q2 2022): 0; Sold out in Q2 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 1; Since Q1 2022

Holdings of OVID by Royce & Associates LP, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2022	0	$0	0.0%	−11,811−100.0%	Sold out	Holders
Q1 2022	11,811	$37.0K	<0.1%	+11,811	New	Holders